연구동향 분석
박사

허혈-재관류에 의한 신장 손상 동물 모델에서 지방 유래 기질 혈관 분획 주입 후 신기능 회복에 대한 연구 = The recovery of renal function after administered adipose tissue-derived stromal vascular fraction in rat model of ischemia-reperfusion–induced acute kidney injury

이천우 2015년

논문상세정보
인용/피인용
' 허혈-재관류에 의한 신장 손상 동물 모델에서 지방 유래 기질 혈관 분획 주입 후 신기능 회복에 대한 연구 = The recovery of renal function after administered adipose tissue-derived stromal vascular fraction in rat model of ischemia-reperfusion–induced acute kidney injury' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • acute kidney injury
  • ischemia-reperfusion injury
  • renal function
  • stromal vascular fraction
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
94 0

0.0%

' 허혈-재관류에 의한 신장 손상 동물 모델에서 지방 유래 기질 혈관 분획 주입 후 신기능 회복에 대한 연구 = The recovery of renal function after administered adipose tissue-derived stromal vascular fraction in rat model of ischemia-reperfusion–induced acute kidney injury' 의 참고문헌

  • da Silva LB, Palma PV, Cury PM, Bueno V. Evaluation of stem celladministration in a model of kidney ischemia-reperfusion injury.International immunopharmacology 2007;7(13):1609-16.
  • You D, Jang MJ, Kim BH, Song G, Lee C, Suh N, et al. Comparative30study of autologous stromal vascular fraction and adipose-derivedstem cells for erectile function recovery in a rat model of cavernousnerve injury. Stem cells translational medicine 2015;4(4):351-8.
  • Yip HK, Chang LT, Wu CJ, Sheu JJ, Youssef AA, Pei SN, et al.Autologous bone marrow-derived mononuclear cell therapy preventsthe damage of viable myocardium and improves rat heart functionfollowing acute anterior myocardial infarction. Circulation journal :official journal of the Japanese Circulation Society 2008;72(8):1336-45.
  • Yasuda K, Ozaki T, Saka Y, Yamamoto T, Gotoh M, Ito Y, et al.Autologous cell therapy for cisplatin-induced acute kidney injury byusing non-expanded adipose tissue-derived cells. Cytotherapy2012;14(9):1089-100.
  • Williams JA. Evaluate the Use of Liposuction and Cell SeparationDevices for Autologous Fat (Adi- pose) Derived Cells to Treat theSymptoms of Erectile Dysfunction.https://www.clinicaltrials.gov/ct2/show/NCT01601353?term=NCT01601353&rank=1
  • Wang Y, He J, Pei X, Zhao W. Systematic review and meta-analysis ofmesenchymal stem/stromal cells therapy for impaired renal function insmall animal models. Nephrology (Carlton, Vic) 2013;18(3):201-8.
  • Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C.Vasculotropic, paracrine actions of infused mesenchymal stem cellsare important to the recovery from acute kidney injury. Americanjournal of physiology Renal physiology 2007;292(5):F1626-35.
  • Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C.Administered mesenchymal stem cells protect against ischemic acuterenal failure through differentiation-independent mechanisms.American journal of physiology Renal physiology 2005;289(1):F31-42.
  • Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologousand allogeneic marrow stromal cells are safe and effective for thetreatment of acute kidney injury. Stem cells and development2009;18(3):475-85.
  • Shih YC, Lee PY, Cheng H, Tsai CH, Ma H, Tarng DC. Adiposederivedstem cells exhibit antioxidative and antiapoptotic properties torescue ischemic acute kidney injury in rats. Plastic and reconstructivesurgery 2013;132(6):940e-51e.
  • Ning H, Liu G, Lin G, Garcia M, Li LC, Lue TF, et al. Identification ofan aberrant cell line among human adipose tissue-derived stem cellisolates. Differentiation; research in biological diversity2009;77(2):172-80.
  • Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al.Mesenchymal stem cells are renotropic, helping to repair the kidneyand improve function in acute renal failure. Journal of the AmericanSociety of Nephrology : JASN 2004;15(7):1794-804.
  • Melnikov VY, Faubel S, Siegmund B, Lucia MS, Ljubanovic D,Edelstein CL. Neutrophil-independent mechanisms of caspase-1- andIL-18-mediated ischemic acute tubular necrosis in mice. The Journal31of clinical investigation 2002;110(8):1083-91.
  • Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS.Mobilized human hematopoietic stem/progenitor cells promote kidneyrepair after ischemia/reperfusion injury. Circulation322010;121(20):2211-20.
  • Lee PY, Chien Y, Chiou GY, Lin CH, Chiou CH, Tarng DC. Inducedpluripotent stem cells without c-Myc attenuate acute kidney injury viadownregulating the signaling of oxidative stress and inflammation inischemia-reperfusion rats. Cell transplantation 2012;21(12):2569-85.
  • Lange C, Togel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR,33et al. Administered mesenchymal stem cells enhance recovery fromischemia/reperfusion-induced acute renal failure in rats. Kidneyinternational 2005;68(4):1613-7.
  • La Manna G, Bianchi F, Cappuccilli M, Cenacchi G, Tarantino L,Pasquinelli G, et al. Mesenchymal stem cells in renal function recoveryafter acute kidney injury: use of a differentiating agent in a rat model.Cell transplantation 2011;20(8):1193-208.
  • Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al.Local delivery of marrow-derived stromal cells augments collateralperfusion through paracrine mechanisms. Circulation2004;109(12):1543-9.
  • Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al.Marrow-derived stromal cells express genes encoding a broadspectrum of arteriogenic cytokines and promote in vitro and in vivoarteriogenesis through paracrine mechanisms. Circulation research2004;94(5):678-85.
  • Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, et al.Insulin-like growth factor-1 sustains stem cell mediated renal repair.Journal of the American Society of Nephrology : JASN2007;18(11):2921-8.
  • Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, CamussiG. Mesenchymal stem cells contribute to the renal repair of acutetubular epithelial injury. International journal of molecular medicine2004;14(6):1035-41.
  • Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al.Paracrine action accounts for marked protection of ischemic heart byAkt-modified mesenchymal stem cells. Nature medicine2005;11(4):367-8.
  • Elliot L. Safety and Clinical Outcomes Study: SVF Deployment forOrthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions.https://www.clinicaltrials.gov/ct2/show/NCT01953523?term=NCT01953523&rank=1
  • Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T,et al. Restoration of tubular epithelial cells during repair of thepostischemic kidney occurs independently of bone marrow-derivedstem cells. The Journal of clinical investigation 2005;115(7):1743-55.
  • Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R,Nagler A, et al. Transplantation of human hematopoietic stem cellsinto ischemic and growing kidneys suggests a role in vasculogenesisbut not tubulogenesis. Stem cells (Dayton, Ohio) 2006;24(5):1185-93.
  • Chen YT, Sun CK, Lin YC, Chang LT, Chen YL, Tsai TH, et al.Adipose-derived mesenchymal stem cell protects kidneys againstischemia-reperfusion injury through suppressing oxidative stress andinflammatory reaction. Journal of translational medicine 2011;9:51.
  • Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adiposederivedstromal cells: Their identity and uses in clinical trials, anupdate. World journal of stem cells 2011;3(4):25-33.
  • Burst VR, Gillis M, Putsch F, Herzog R, Fischer JH, Heid P, et al. Poorcell survival limits the beneficial impact of mesenchymal stem celltransplantation on acute kidney injury. Nephron Experimentalnephrology 2010;114(3):e107-16.
  • Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, etal. Stromal cells from the adipose tissue-derived stromal vascularfraction and culture expanded adipose tissue-derived stromal/stemcells: a joint statement of the International Federation for AdiposeTherapeutics and Science (IFATS) and the International Society forCellular Therapy (ISCT). Cytotherapy 2013;15(6):641-8.
  • Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cellsprotect against acute tubular injury via an endocrine effect. Journal ofthe American Society of Nephrology : JASN 2007;18(9):2486-96.
  • Behr L, Hekmati M, Fromont G, Borenstein N, Noel LH, Lelievre-Pegorier M, et al. Intra renal arterial injection of autologousmesenchymal stem cells in an ovine model in the postischemic kidney.Nephron Physiology 2007;107(3):p65-76.